Dan Williams

Dan Williams

Company: Synaptix Bio

Job title: Chief Executive Officer


Spotlight on SynaptixBio – A Virtual Approach to Developing an Oligonucleotide Therapy for a CNS Disorder 2:30 pm

TUBB4A Leukodystrophy and it’s suitability for an oligonucleotide therapeutic approach SynaptixBio’s virtual strategy to outsourcing and developing a therapeutic Exploring the pros and cons of applying a virtual model to development – learnings from a start-up biotechnology companyRead more

day: Day One

© Copyright 2022 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.